Skip to main content

Coffee consumption and risk of renal cancer: a meta-analysis of cohort evidence

Abstract

Purpose

There is increasing evidence that coffee consumption is related to reduced risks for some cancers, but the evidence for renal cancer is inconclusive. Therefore, we conducted a meta-analysis to summarize the cohort evidence of this relationship.

Methods

A literature search was performed in PubMed and Embase through February 2021. Meta-analyses using a random effects model were conducted for reported relative risk estimates (RRs) relating coffee intake and renal cancer incidence or mortality. We also performed a two-stage random effects exposure–response meta-analysis. Between-study heterogeneity was assessed.

Results

In a meta-analysis of the ten identified cohort studies, we found a summary RR of 0.88 [95% confidence interval (CI) 0.78–0.99] relating the highest vs. the lowest category of coffee intake and renal cancer, with no significant between-study heterogeneity observed (I2 = 35%, p = 0.13). This inverse association remained among studies of incident cancers (RR 0.85, 95% CI 0.76–0.96) and studies adjusting for smoking and body mass index (RR 0.87, 95% CI 0.77–0.99).

Conclusions

Our findings from this meta-analysis of the published cohort evidence are suggestive of an inverse association between coffee consumption and renal cancer risk.

This is a preview of subscription content, access via your institution.

Fig. 1
Fig. 2
Fig. 3
Fig. 4

Data availability

All data reported in this manuscript are found in the literature as cited in the text.

Code availability

Researchers who are interested in R codes for the analyses may contact the authors.

Abbreviations

MeSH:

Medical subject headings

MOOSE:

Meta-analysis of observational studies in epidemiology

RR:

Relative risk

CI:

Confidence interval

CKD:

Chronic kidney disease

BMI:

Body mass index

References

  1. 1.

    Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A (2018) Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin 68:394–424

    Article  Google Scholar 

  2. 2.

    Siegel RL, Miller KD, Jemal A (2018) Cancer statistics, 2018. CA Cancer J Clin 68:7–30

    PubMed  Article  PubMed Central  Google Scholar 

  3. 3.

    Howlader N, Noone AM, Krapcho M et al (2020) SEER cancer statistics review, 1975–2017. National Cancer Institute, Bethesda, MD

    Google Scholar 

  4. 4.

    Chow W-H, Devesa SS, Warren JL, Fraumeni JF Jr (1999) Rising incidence of renal cell cancer in the United States. JAMA 281:1628–1631

    CAS  PubMed  Article  Google Scholar 

  5. 5.

    Bergström A, Hsieh C, Lindblad P, Lu C, Cook N, Wolk A (2001) Obesity and renal cell cancer–a quantitative review. Br J Cancer 85:984–990

    PubMed  PubMed Central  Article  Google Scholar 

  6. 6.

    Bjørge T, Tretli S, Engeland A (2004) Relation of height and body mass index to renal cell carcinoma in two million Norwegian men and women. Am J Epidemiol 160:1168–1176

    PubMed  Article  Google Scholar 

  7. 7.

    Hidayat K, Du X, Zou S-Y, Shi B-M (2017) Blood pressure and kidney cancer risk: meta-analysis of prospective studies. J Hypertens 35:1333–1344

    CAS  PubMed  Article  Google Scholar 

  8. 8.

    Cumberbatch MG, Rota M, Catto JW, La Vecchia C (2016) The role of tobacco smoke in bladder and kidney carcinogenesis: a comparison of exposures and meta-analysis of incidence and mortality risks. Eur Urol 70:458–466

    CAS  PubMed  Article  Google Scholar 

  9. 9.

    Song DY, Song S, Song Y, Lee JE (2012) Alcohol intake and renal cell cancer risk: a meta-analysis. Br J Cancer 106:1881–1890

    CAS  PubMed  PubMed Central  Article  Google Scholar 

  10. 10.

    Gómez-Ruiz JÁ, Leake DS, Ames JM (2007) In vitro antioxidant activity of coffee compounds and their metabolites. J Agric Food Chem 55:6962–6969

    PubMed  Article  CAS  Google Scholar 

  11. 11.

    Cavin C, Holzhaeuser D, Scharf G, Constable A, Huber W, Schilter B (2002) Cafestol and kahweol, two coffee specific diterpenes with anticarcinogenic activity. Food Chem Toxicol 40:1155–1163

    CAS  PubMed  Article  Google Scholar 

  12. 12.

    Poole R, Kennedy OJ, Roderick P, Fallowfield JA, Hayes PC, Parkes J (2017) Coffee consumption and health: umbrella review of meta-analyses of multiple health outcomes. BMJ 359:J5024

    PubMed  PubMed Central  Article  Google Scholar 

  13. 13.

    Lukic M, Guha N, Licaj I et al (2018) Coffee drinking and the risk of endometrial cancer: an updated meta-analysis of observational studies. Nutr Cancer 70:513–528

    CAS  PubMed  Article  Google Scholar 

  14. 14.

    Wijarnpreecha K, Thongprayoon C, Thamcharoen N, Panjawatanan P, Cheungpasitporn W (2017) Association between coffee consumption and risk of renal cell carcinoma: a meta-analysis. Intern Med J 47:1422–1432

    PubMed  Article  Google Scholar 

  15. 15.

    Gibson TM, Ferrucci LM, Tangrea JA, Schatzkin A (2010) Epidemiological and clinical studies of nutrition. Semin Oncol 37:282–296

    PubMed  PubMed Central  Article  Google Scholar 

  16. 16.

    Gapstur SM, Anderson RL, Campbell PT et al (2017) Associations of coffee drinking and cancer mortality in the cancer prevention study-II. Cancer Epidemiol Biomarkers Prev 26:1477–1486

    CAS  PubMed  Article  Google Scholar 

  17. 17.

    Lukic M, Nilsson LM, Skeie G, Lindahl B, Braaten T (2018) Coffee consumption and risk of rare cancers in Scandinavian countries. Eur J Epidemiol 33:287–302

    PubMed  Article  Google Scholar 

  18. 18.

    Park S-Y, Freedman ND, Haiman CA, Le Marchand L, Wilkens LR, Setiawan VW (2018) Prospective study of coffee consumption and cancer incidence in non-white populations. Cancer Epidemiol Biomarkers Prev 27:928–935

    PubMed  PubMed Central  Article  Google Scholar 

  19. 19.

    Rhee J, Loftfield E, Freedman ND, Liao LM, Sinha R, Purdue MP (2021) Coffee consumption and risk of renal cell carcinoma in the NIH-AARP Diet and Health Study. Int J Epidemiol. https://doi.org/10.1093/ije/dyab011

    Article  PubMed  Google Scholar 

  20. 20.

    Stroup DF, Berlin JA, Morton SC et al (2000) Meta-analysis of observational studies in epidemiology: a proposal for reporting. JAMA 283:2008–2012

    CAS  PubMed  Article  Google Scholar 

  21. 21.

    Wells GA, Tugwell P, O’Connell D, et al. The Newcastle-Ottawa Scale (NOS) for assessing the quality of nonrandomized studies in meta-analyses. http://www.ohri.ca/programs/clinical_epidemiology/oxford.asp. Accessed 15 April, 2021

  22. 22.

    Greenland S, Longnecker MP (1992) Methods for trend estimation from summarized dose-response data, with applications to meta-analysis. Am J Epidemiol 135:1301–1309

    CAS  PubMed  Article  Google Scholar 

  23. 23.

    Orsini N, Bellocco R, Greenland S (2006) Generalized least squares for trend estimation of summarized dose–response data. Stata J 6:40–57

    Article  Google Scholar 

  24. 24.

    DerSimonian R, Laird N (1986) Meta-analysis in clinical trials. Control Clin Trials 7:177–188

    CAS  PubMed  PubMed Central  Article  Google Scholar 

  25. 25.

    Jackson D, White IR, Thompson SG (2010) Extending DerSimonian and Laird’s methodology to perform multivariate random effects meta-analyses. Stat Med 29:1282–1297

    PubMed  Article  Google Scholar 

  26. 26.

    Crippa A, Discacciati A, Larsson SC, Wolk A, Orsini N (2014) Coffee consumption and mortality from all causes, cardiovascular disease, and cancer: a dose-response meta-analysis. Am J Epidemiol 180:763–775

    PubMed  Article  Google Scholar 

  27. 27.

    Washio M, Mori M, Sakauchi F et al (2005) Risk factors for kidney cancer in a Japanese population: findings from the JACC Study. J Epidemiol 15:S203–S211

    PubMed  Article  Google Scholar 

  28. 28.

    Lee JE, Hunter DJ, Spiegelman D et al (2007) Intakes of coffee, tea, milk, soda and juice and renal cell cancer in a pooled analysis of 13 prospective studies. Int J Cancer 121:2246–2253

    CAS  PubMed  Article  Google Scholar 

  29. 29.

    Orsini N, Li R, Wolk A, Khudyakov P, Spiegelman D (2012) Meta-analysis for linear and nonlinear dose-response relations: examples, an evaluation of approximations, and software. Am J Epidemiol 175:66–73

    PubMed  Article  Google Scholar 

  30. 30.

    Stensvold I, Jacobsen BK (1994) Coffee and cancer: a prospective study of 43,000 Norwegian men and women. Cancer Causes Control 5:401–408

    CAS  PubMed  Article  Google Scholar 

  31. 31.

    Nilsson LM, Johansson I, Lenner P, Lindahl B, Van Guelpen B (2010) Consumption of filtered and boiled coffee and the risk of incident cancer: a prospective cohort study. Cancer Causes Control 21:1533–1544

    PubMed  Article  Google Scholar 

  32. 32.

    Allen N, Balkwill A, Beral V, Green J, Reeves G (2011) Fluid intake and incidence of renal cell carcinoma in UK women. Br J Cancer 104:1487–1492

    CAS  PubMed  PubMed Central  Article  Google Scholar 

  33. 33.

    Hashibe M, Galeone C, Buys SS et al (2015) Coffee, tea, caffeine intake, and the risk of cancer in the PLCO cohort. Br J Cancer 113:809

    CAS  PubMed  PubMed Central  Article  Google Scholar 

  34. 34.

    Egger M, Smith GD, Schneider M, Minder C (1997) Bias in meta-analysis detected by a simple, graphical test. BMJ 315:629–634

    CAS  PubMed  PubMed Central  Article  Google Scholar 

  35. 35.

    Higgins JP, Thompson SG (2002) Quantifying heterogeneity in a meta-analysis. Stat Med 21:1539–1558

    PubMed  Article  PubMed Central  Google Scholar 

  36. 36.

    Viechtbauer W (2010) Conducting meta-analyses in R with the metafor package. J Stat Softw 36:1–48

    Article  Google Scholar 

  37. 37.

    Crippa A, Orsini N (2016) Multivariate dose-response meta-analysis: the dosresmeta R package. J Stat Softw 72:1–15

    Article  Google Scholar 

  38. 38.

    Team RC (2013) R: A language and environment for statistical computing. Austria, Vienna

    Google Scholar 

  39. 39.

    Hsieh JJ, Purdue MP, Signoretti S et al (2017) Renal cell carcinoma. Nat Rev Dis Primers 3:17009

    PubMed  PubMed Central  Article  Google Scholar 

  40. 40.

    Yu X, Bao Z, Zou J, Dong J (2011) Coffee consumption and risk of cancers: a meta-analysis of cohort studies. BMC Cancer 11:1–11

    Article  CAS  Google Scholar 

  41. 41.

    Swanson JA, Lee JW, Hopp JW (1994) Caffeine and nicotine: a review of their joint use and possible interactive effects in tobacco withdrawal. Addict Behav 19:229–256

    CAS  PubMed  Article  Google Scholar 

  42. 42.

    Choi MJ, Park EJ, Oh JH et al (2011) Cafestol, a coffee-specific diterpene, induces apoptosis in renal carcinoma Caki cells through down-regulation of anti-apoptotic proteins and Akt phosphorylation. Chem Biol Interact 190:102–108

    CAS  PubMed  Article  Google Scholar 

  43. 43.

    Jhee JH, Nam KH, An SY et al (2018) Effects of coffee intake on incident chronic kidney disease: a community-based prospective cohort study. Am J Med 131:1482–1490

    CAS  PubMed  Article  Google Scholar 

  44. 44.

    Hu EA, Selvin E, Grams ME, Steffen LM, Coresh J, Rebholz CM (2018) Coffee consumption and incident kidney disease: results from the Atherosclerosis Risk in Communities (ARIC) Study. Am J Kidney Dis 72:214–222

    PubMed  PubMed Central  Article  Google Scholar 

  45. 45.

    Bigotte Vieira M, Magriço R, Viegas Dias C, Leitão L, Neves JS (2019) Caffeine consumption and mortality in chronic kidney disease: a nationally representative analysis. Nephrol Dial Transplant 34:974–980

    PubMed  Article  CAS  Google Scholar 

  46. 46.

    Herber-Gast G-CM, Hv E, Verschuren WM et al (2016) Coffee and tea consumption in relation to estimated glomerular filtration rate: results from the population-based longitudinal Doetinchem Cohort Study. Am J Clin Nutr 103:1370–1377

    CAS  PubMed  Article  Google Scholar 

  47. 47.

    Van Dam RM, Feskens EJ (2002) Coffee consumption and risk of type 2 diabetes mellitus. Lancet 360:1477–1478

    PubMed  Article  Google Scholar 

  48. 48.

    Poole R, Ewings S, Parkes J, Fallowfield JA, Roderick P (2019) Misclassification of coffee consumption data and the development of a standardised coffee unit measure. BMJ Nutr Prev Health. https://doi.org/10.1136/bmjnph-2018-000013

    Article  PubMed  PubMed Central  Google Scholar 

Download references

Funding

This research was supported by the Intramural Research Program of the National Institutes of Health, National Cancer Institute, Division of Cancer Epidemiology & Genetics.

Author information

Affiliations

Authors

Contributions

JR: designed study, extracted data, conducted analyses, and wrote the manuscript. RKL contributed to literature searches, literature review, data retrieval and provided feedback to the manuscript. MPP critically reviewed the manuscript and supervised the project.

Corresponding author

Correspondence to Mark P. Purdue.

Ethics declarations

Conflict of interest

The authors declare that they have no conflict of interest.

Ethical approval and consent to participate

The systematic review and meta-analysis do not require ethical approval or consent to participate.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and Permissions

About this article

Verify currency and authenticity via CrossMark

Cite this article

Rhee, J., Lim, R.K. & Purdue, M.P. Coffee consumption and risk of renal cancer: a meta-analysis of cohort evidence. Cancer Causes Control (2021). https://doi.org/10.1007/s10552-021-01506-1

Download citation

Keywords

  • Coffee
  • Kidney cancer
  • Cohort study
  • Meta-analysis